Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by ANALIAS00


T.TH

RE:RE:Better then expected

From the corporate presentation : 10-15% sales growth expected in 2018 So 13%...

April 5, 2018

T.TH

Question I would like to hear tomorrow

One month after launch sales should not be the best indicator to evaluate the...

April 4, 2018

T.TH

RE:RE:RE:Medical Mutual ask resistance to three drugs in three classe

JesseCheng wrote: Maybe somebody can go to FDA's website and tell them...

April 2, 2018

T.TH

RE:RE:RE:RE:RE:RE:RE:Very Interesting New CYDY presentation

longterm56 wrote:   PoorOpinion wrote:    ...

March 28, 2018

T.TH

RE:Fuzeon sales

What happen in 2008 ? New product came into play or all patient market were...

March 20, 2018

T.TH

RE:RE:RE:RE:Article in Montreal newspaper La Presse

You take the worst case scenario and it is still positive for the EPS and the...

March 19, 2018

T.TH

RE:Orphan drug pricing

jfm1330 wrote: Those who think Trogarzo (Ibalizumab) will be expensive at...

March 13, 2018

T.TH

EvaluatePharma: Orphan Drug Report 2017

Mmmmm ....very interesting report.  I am sure SPECO1 and JFM1330 will be...

March 13, 2018

T.TH

RE:RE:RE:RE:RE:Philippe Dubuc, chef de la direction financière de Theratech

jfm1330 wrote: SPCEO1 wrote: I am sure Luc is indeed ticked off about...

March 12, 2018

T.TH

RE:RE:RE:Philippe Dubuc, chef de la direction financière de Theratech

jfm1330 wrote: Dubuc said in the interview that they expect the market in the...

March 12, 2018

T.TH

RE:RE:RE:10$ ?

Can payors affort 10 000 x $82 600 per year ??? Those are big numbers. Is it...

March 9, 2018

T.TH

RE:Analyst reports?!

SPCEO1 (who else) provided the following: CIBC from $10.30 to $15 Canaccord...

March 7, 2018

T.TH

Answer about Approval in CANADA

Someone ask the question about when they would be asking for approval in...

March 7, 2018

T.TH

RE:RE:Taimed +10% at opening

http://www.twse.com.tw/en/page/products/trading_rules/mechanism01.html "...

March 6, 2018

T.TH

RE:Peel Pub Reunion for all Montrealers

Cant make it to Peel Pub :( Have good one. sambanout wrote: Congradulations...

March 6, 2018

T.TH

Conference call

Can someone paste the info for the confrence call please. Thanks

March 6, 2018

T.TH

PDUFA date

FDA's response must be known days and weeks before PDUFA date. I wonder...

March 4, 2018

T.TH

OTIC got its approval from the FDA

This is not making any difference but there are 3 left before THERF. ...

March 2, 2018

T.TH

RE:RE:33 days until april 3

We are in a situation where we (few investors on this board) believe we are...

March 2, 2018

T.TH

RE:RE:RE:New Investor Presentation

I am not spreading anything.   You can also say that the total US...

February 26, 2018

Featured Company